HSD17B13-IN-34 (75) functions as an inhibitor of 17β-Hydroxysteroid dehydrogenases (HSD17B13), exhibiting potency with an IC 50 value of less than 0.1 μM against Estradiol. It is utilized primarily in the research of NAFLD (Nonalcoholic fatty liver diseases) [1].